J Korean Med Assoc.  2013 Jul;56(7):625-631. 10.5124/jkma.2013.56.7.625.

Inhalation medications in chronic airway disease

Affiliations
  • 1Department of Internal Medicine, Konkuk University College of Medicine, Seoul, Korea. Khyou@kuh.ac.kr

Abstract

Chronic airway diseases (asthma and chronic obstructive lung disease) are common and their prevalence is increasing worldwide. The most effective method for drug delivery for the treatment of patients with chronic airway diseases is via an inhaler device. The guidelines on asthma and chronic obstructive pulmonary disease (COPD) recommend inhaler medication for the treatment of these patients. Inhaled medications have several advantages, including faster onset of action, a lower dose of medicine, and reduced adverse effects. To maximize the effect of inhaled medication, patients must use the inhaler device correctly; thus patients should receive training and education in the use of the device. There are now many kinds of inhaler devices on the market, such that the appropriate choice of inhaler device for each patient plays a crucial role in achieving a good outcomes from treatment. Correct use of inhalation devices will maximize the beneficial effects of therapy. A detailed assessment of the patient's coordination and inspiratory flow patterns could allow for the correct use of the most suitable inhaler medication for each patient. Successful inhalation therapy can increase the possibility of controlling airway diseases.

Keyword

Inhaler medication; Asthma; Chronic obstructive pulmonary disease; Equipment and supplies

MeSH Terms

Asthma
Equipment and Supplies
Humans
Inhalation
Lung
Nebulizers and Vaporizers
Prevalence
Pulmonary Disease, Chronic Obstructive
Respiratory Therapy
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error